Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership
Learn More
close
Fred Hutch - Cures Start Here®
Research
Pioneering Scientific Research
Research Areas
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Autoimmune Diseases
Cancers
COVID-19
Genetic Disorders
Herpes
HIV/AIDS
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Cook for Your Life
Faculty & Lab Directory
COVID-19 Clinical Research Center
Office of Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Available Technologies
Collaborations & Spinoffs
Commercialization
Events & Conferences
Team
News
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Campus Map
Virtual Campus Visit
Scientific Staff Directory
Global Locations
Careers
Internships
Science Education Outreach (SciEd)
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Donate Cryptocurrency
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Fundraise for Fred Hutch
Obliteride
Climb to Fight Cancer
Create Your Own
Log In to Your Fundraiser
Attend an Event
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Join a Gift Club
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Submit
Donate
Now
Submit
Research
Pioneering Scientific Research
Research Areas
Research Areas
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Diseases
Autoimmune Diseases
Cancers
COVID-19
Genetic Disorders
Herpes
HIV/AIDS
Divisions
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Cook for Your Life
Faculty & Lab Directory
COVID-19 Clinical Research Center
Office of Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Business Development
Available Technologies
Collaborations & Spinoffs
Commercialization
Events & Conferences
Team
News
Driving Innovation
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Contact Us
Campus Map
Virtual Campus Visit
Scientific Staff Directory
Global Locations
Careers
Internships
Science Education Outreach (SciEd)
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Donate Cryptocurrency
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Fundraise for Fred Hutch
Fundraise for Fred Hutch
Obliteride
Climb to Fight Cancer
Create Your Own
Log In to Your Fundraiser
Attend an Event
Support Our Science
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Join a Gift Club
Other Ways to Give
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Donate Now
Hutch News
Science Spotlight
News Releases
Scientific Publications
For the Media
Media Coverage
Stories tagged checkpoint inhibitors
Results per Page:
20
5
10
20
50
100
Fred Hutch mourns sudden loss of Dr. Martin ‘Mac’ Cheever
A long career devoted to bringing immunotherapies from bench to bedside
Hutch News - September 28, 2021
Tags
Public Health Sciences
Clinical Research
Martin Cheever
CITN network
Immunotherapy Integrated Research Center
immunotherapy development
Frederick R Appelbaum
Philip D Greenberg
cellular therapy
CAR t-cell
checkpoint inhibitors
cancer vaccines
radioimmunotherapy
Share
How RNA-altering drugs might improve anticancer immunotherapies
In lab study, brief disruptions of gene machinery make tumor cells more 'visible' to immune system
Hutch News - June 24, 2021
Tags
basic sciences
Robert Bradley
immunotherapy development
checkpoint inhibitors
RNA
alternative rna splicing
pembrolizumab
Herbold Computational Biology Program
Cancer Neo-antigen
COVID-19
Basic Sciences
Public Health Sciences
Herbold Computational Biology Program
Share
Repair of key immune organ triggered by change in how immune cells die
Scientists learn how dying T cells promote regrowth of thymus
Hutch News - December 07, 2020
Tags
cancer immunotherapy
Jarrod Dudakov
thymus regeneration
CD8+ T cells
Clinical Research
checkpoint inhibitors
Share
New regional collaborations will accelerate innovation in data-intensive medical science
Three research teams in Washington, Oregon and British Columbia receive pilot funding from Cascadia Data Alliance
Hutch News - November 05, 2020
Tags
Cascadia Data Alliance
data science
Microsoft
Raphael Gottardo
artificial intelligence
Gavin Ha
Julie Gralow
Public Health Sciences
Human Biology
computational biology
genomics
Breast Cancer
microbiome
David Fredricks
Vaccine and Infectious Disease
Tumor specific translational research
Transplant and Immunotherapy
checkpoint inhibitors
cancer diagnosis
pathology
Ovarian Cancer
machine learning
Share
Immunotherapy trial in advanced bladder and other urinary tract cancers shows 'exciting' results
'Practice-changing' data shows patients with advanced urothelial carcinoma survive longer with immune-boosting drug after chemo
Hutch News - September 18, 2020
Tags
Bladder Cancer
immunotherapy
Clinical Research
Transplant and Immunotherapy
Petros Grivas
checkpoint inhibitors
urothelial
ASCO 2021
Share
Study links common immune cell to failure of checkpoint inhibitors in lung cancer
New research suggests how to better predict which patients will respond to immunotherapy
Hutch News - December 19, 2019
Tags
Transplant and Immunotherapy
Lung Cancer
non-small cell lung cancer
checkpoint inhibitors
Clinical Research
McGarry Houghton
Share
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
Hutch News - August 06, 2019
Tags
Lung Cancer
McGarry Houghton
Christina Baik
Stanley R Riddell
Sylvia Lee
David MacPherson
Renato Martins
Paul D Lampe
immunotherapy research
checkpoint inhibitors
targeted therapy
precision diagnostics
Transplant and Immunotherapy
Good News
lung cancer spore
Share
Cancer cells reconnect with their inner child to evade immunotherapy
Turning on an embryonic gene may help some tumors resist immune checkpoint inhibitors
Hutch News - July 18, 2019
Tags
Robert Bradley
Stephen J Tapscott
Basic Sciences
Human Biology
Clinical Research
Public Health Sciences
cancer genetics
immunotherapy
checkpoint inhibitors
Molecular basis of cancer
Transplant and Immunotherapy
Share
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment
Hutch News - May 14, 2019
Tags
IPCR
Prostate Cancer
health disparities
Peter Nelson
Marian Neuhouser
Heather Cheng
Evan Yu
Daniel Lin
diet disease association
Health Risks and Benefits of Dietary Supplements
precision medicine
PET scan
immunotherapy
checkpoint inhibitors
BRCA
John Lee
genetic test
Human Biology
Clinical Research
Tumor specific translational research
Share
Dr. Cameron Howard Lee named 2019 Helen Hay Whitney Fellow
Biggins Lab postdoc will look at relationship between protein production and key cell-cycle checkpoint
Hutch News - November 26, 2018
Tags
Biggins Lab
Sue Biggins
Basic Sciences
chromosome
Good News
checkpoint inhibitors
kinetochores
Molecular basis of cancer
Share
Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it
How a new technology solved a mystery and honors one man’s legacy
Hutch News - September 24, 2018
Tags
immunotherapy
Transplant and Immunotherapy
merkel cell carcinoma
Aude Chapuis
Kelly Paulson
Paul Nghiem
t cell therapy
checkpoint inhibitors
gene expression
hla gene
Clinical Research Division (CRD)
clinical trials
pathogen-associated malignancies
Share
Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
‘Incredibly big change’ in treatment of deadly skin cancer, new data show
Hutch News - June 04, 2018
Tags
Paul Nghiem
Clinical Research
immunotherapy
Transplant and Immunotherapy
checkpoint inhibitors
pembrolizumab
merkel cell carcinoma
skin cancer
ASCO 2018
pathogen-associated malignancies
Share
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials
Hutch News - November 07, 2017
Tags
cancer immunotherapy trials network
hiv
pembrolizumab
checkpoint inhibitors
hiv aids
kaposi
Sarcoma
Pathogen-Associated Malignancies IRC
immunotherapy
immunotherapy research
clinical trials
infection-related cancers
Vaccine and Infectious Disease Division (VIDD)
global oncology
Thomas Uldrick
ASCO 2019
ASCO
scientific conferences
Share
The tumor microenvironment: How cancer fools healthy neighboring cells
‘Tumor microenvironment’ research underscores why we need cancer immunotherapy — and how to make it work for more patients
Hutch News - July 18, 2017
Tags
Clinical Research
immunotherapy
Lung Cancer
Ovarian Cancer
McGarry Houghton
Philip D Greenberg
Robert Pierce
T cell
t cell therapy
checkpoint inhibitors
pembrolizumab
solid tumors
Transplant and Immunotherapy
Share
She was given a few months to live. Then, ‘a true miracle.’
Hutch News - July 11, 2017
Tags
Clinical Research
Transplant and Immunotherapy
checkpoint inhibitors
immunotherapy
merkel cell carcinoma
Paul Nghiem
clinical trials
patient stories
Share
Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy
Immune-based treatments move from the fringes to the spotlight
Hutch News - June 16, 2017
Tags
immunotherapy
Transplant and Immunotherapy
Clinical Research
Sylvia Lee
Renato Martins
Philip D Greenberg
Michael Jensen
Juno Therapeutics
Adaptive Biotechnologies
chimeric antigen receptor
adoptive t cell therapy
CAR t-cell
tumor infiltrating lymphocyte
checkpoint inhibitors
Lung Cancer
Melanoma
Leukemia
pediatric
Share
Triple therapy for rare skin cancer shows promise in small, early-stage trial
Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma
Hutch News - May 31, 2017
Tags
Aude Chapuis
Paul Nghiem
merkel cell carcinoma
immunotherapy
t cell therapy
checkpoint inhibitors
Clinical Research
metastasis
ASCO 2017
Transplant and Immunotherapy
Pathogen-Associated Malignancies IRC
Share
Immunotherapy trial in rare skin cancer named one of 2016’s major advances in clinical cancer research and care
Study found long-lasting responses to immunotherapy drug in patients with Merkel cell carcinoma
Hutch News - February 02, 2017
Tags
Paul Nghiem
Martin Cheever
cancer immunotherapy trials network
merkel cell carcinoma
Skin Cancer
Transplant and Immunotherapy
checkpoint inhibitors
Good News
Share
Fred Hutchinson Cancer Center
Hutch News
Last Modified, April 02, 2020